Severe systemic vasculitis induced by ibrutinib
CONCLUSION: The mechanism of action of ibrutinib does not explain the occurrence of vasculitis and an immunoallergic mechanism is suspected.PMID:37951781 | DOI:10.1016/j.revmed.2023.10.448
Source: Revue de Medecine Interne - Category: Internal Medicine Authors: M Fenot P Woaye Hune S Vigouroux G Veyrac C Poiraud Source Type: research
More News: Chronic Leukemia | Chronic Lymphocytic Leukemia | Corticosteroid Therapy | Internal Medicine | Leukemia | Skin | Skin Biopsy | Toxicology | Vasculitis